Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
Understanding, diagnosing, managing, and more.
View Issue
Sponsored by Elios Vision, Inc.
View Insert
Sponsored by Sight Sciences
Editorially independent content, supported with advertising from Zeiss
Sponsored by AbbVie
In This Issue
Callan Navitsky, Editor-in-Chief
The patient is on maximum tolerated medical therapy and has undergone multiple interventions.
Steven R. Sarkisian Jr, MD; Matthew Brink, MD; George R. Reiss, MD; and I. Paul Singh, MD
Strategies and tools for the eye care provider.
Jason Xiao, BA; Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD
Lower levels of macular pigment may be associated with a thinner macular ganglion cell complex.
Thomas Lawler, PhD, and Yao Liu, MD, MS
Looking for risk factors and differences among procedures.
Sayyada (Maela) Hyder, MD, and Sarah H. Van Tassel, MD
Modulating aqueous flow with a titratable shunt may help to minimize complications.
Arsham Sheybani, MD
Perspectives from a new attending surgeon.
Jasdeep Sabharwal, MD, PhD
Four available solutions offer a range of benefits to patients with diverse needs.
Delcora Huggins, BS, and Mona Kaleem, MD
A common clinical encounter at a Hawaiian practice.
Karen Chen, MD, MPhil
A closer look at variations in IOP and the association with glaucoma.
Arthur J. Sit, MD
Color Doppler imaging showed a higher resistive index in patients with NTG versus POAG.
João Barbosa-Breda, MD, PhD; Jan Van Eijgen, MD; Luis Abegão Pinto, MD, PhD; and Ingeborg Stalmans, MD, PhD
An FDA panel unanimously recommended approval of this emerging technology.
Several types of nonglaucomatous optic neuropathy should be considered.
Jay Patel, MD, and Amanda D. Henderson, MD
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.
